LOXL2 plays an essential role in matrix remodelling and fibrogenesis, but in both bleomycin treated mice and patients with IPF, LOXL2 expression is increased [465, 466]. The gene discussed is LOXL2; the disease is idiopathic pulmonary fibrosis.